PP405 is the most promising future treatment for hair loss, aiming to reactivate dormant hair follicles. Clascoterone 5% is the most promising near-term drug, while current strategies include using finasteride or dutasteride to stabilize hair loss and minoxidil to stimulate growth.
PP405 and ABS-201 are promising treatments for male pattern baldness. PP405 shows rapid hairgrowth in human trials, while ABS-201 shows significant regrowth in animal studies but is still in early human trials.
Creatine does not increase DHT levels or cause hair loss. Personal experiences vary, but scientific evidence shows no link between creatine and hair loss.
A 19-year-old is using finasteride, dutasteride, and minoxidil to combat hair loss, seeing improved hair density but minimal hairline regrowth. Users suggest patience, continued treatment, and possibly considering a hair transplant in the future.